437 Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Cutaneous Sarcoidosis: A Systematic Review

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

Efficacy and Safety of Angiogenesis Inhibitors in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

A Systematic Review of the Efficacy and Safety of Fluoridation

Evidence-Based Dentistry
Dentistry
2008English

Association Between Tumor Necrosis Factor-Α and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2019English

No Impact of Tumor Necrosis-Factor Antagonists on the Joint Manifestations of Sarcoidosis

International Journal of General Medicine
Medicine
2013English

Tumor Necrosis Factor-Α Production by Blood Mononuclear Cells in Different Manifestations of Sarcoidosis

Pulmonologiya
PulmonaryRespiratory Medicine
2013English

Systematic Review With Meta-Analysis: The Efficacy and Safety of CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Α Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy

International Journal of Rheumatic Diseases
Rheumatology
2016English

Tumour Necrosis Factor-Α Inhibitors for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: A Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy